subscribeSubscribe
price-trendAsk Us
ORMALVI™: US Product Launch for Primary Periodic Paralysis

ORMALVI™: US Product Launch for Primary Periodic Paralysis
BUSINESSWIRE
08 May 2024
Share Share
Torrent launches First Generic Version of Keveyis Tablets in United States

Torrent launches First Generic Version of Keveyis Tablets in United States
PR NEWSWIRE
06 Apr 2023
Share Share
Torrent`s Generic Dichlorphenamide Receives Approval in the U.S.

Torrent`s Generic Dichlorphenamide Receives Approval in the U.S.
FDA
29 Dec 2022
Share Share
Strongbridge Biopharma plc Reports Third Quarter 2020 Financial Results

Strongbridge Biopharma plc Reports Third Quarter 2020 Financial Results
GLOBENEWSWIRE
29 Oct 2020
Share Share
Why This Little Known Biotech Is Pharma`s New Poster Child for Price Gouging

Why This Little Known Biotech Is Pharma`s New Poster Child for Price Gouging
Alex Keown BIOSPACE
20 Dec 2017
Share Share
Taro introduces Keveyis 50 mg tablets for hyperkalemic, hypokalemic

Taro introduces Keveyis 50 mg tablets for hyperkalemic, hypokalemic
PHARMABIZ
22 Sep 2015
Share Share
Sun Pharma shares gain on hopes paralysis drug may boost sales

Sun Pharma shares gain on hopes paralysis drug may boost sales
FE Online FINANCIAL EXPRESS
14 Aug 2015
Share Share